OTC Pharmaceuticals - Senegal

  • Senegal
  • Revenue in the OTC Pharmaceuticals market amounts to US$91.67m in 2024. The market is expected to grow annually by 9.36% (CAGR 2024-2029).
  • The market's largest segment is the segment Skin Treatment with a market volume of US$22.28m in 2024.
  • In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
  • In relation to total population figures, per person revenues of US$5.03 are generated in 2024.
  • In the OTC Pharmaceuticals market, 12.3% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Senegal has been experiencing significant growth in recent years, driven by a combination of factors such as changing customer preferences, emerging trends in the market, and local special circumstances.

Customer preferences:
Senegalese consumers have shown a growing preference for over-the-counter (OTC) pharmaceutical products due to their convenience and accessibility. The increasing urbanization and busy lifestyles have led to a rise in self-medication practices, where individuals are seeking quick remedies for common ailments. Additionally, the affordability of OTC products compared to prescription medications has also contributed to their popularity among customers.

Trends in the market:
One of the key trends in the OTC Pharmaceuticals market in Senegal is the growing demand for natural and herbal remedies. Consumers are becoming more conscious about their health and are seeking products that are perceived to be more natural and have fewer side effects. This trend is in line with the global shift towards natural and alternative medicines. As a result, there has been an increase in the availability and variety of herbal and natural OTC products in the market. Another trend in the market is the emergence of e-commerce platforms as a popular channel for purchasing OTC pharmaceutical products. Online shopping has gained significant traction in Senegal, driven by factors such as increased internet penetration and the convenience of doorstep delivery. E-commerce platforms offer a wide range of OTC products, allowing customers to compare prices and make informed decisions. This trend has further expanded the reach of OTC pharmaceuticals in the country.

Local special circumstances:
Senegal has a well-established healthcare system, but access to healthcare services can be challenging in certain regions, particularly in rural areas. This has led to an increased reliance on OTC pharmaceuticals as a primary source of healthcare for many individuals. The availability of OTC products in local pharmacies and informal markets has made them easily accessible to a wide range of consumers, including those who may not have easy access to healthcare facilities.

Underlying macroeconomic factors:
The economic growth in Senegal has contributed to the expansion of the OTC Pharmaceuticals market. The country has experienced stable economic growth in recent years, which has resulted in an increase in disposable income and improved living standards. As a result, consumers have more purchasing power to spend on healthcare products, including OTC pharmaceuticals. Furthermore, the government of Senegal has implemented policies to promote the development of the healthcare sector, including the OTC Pharmaceuticals market. These policies aim to improve access to healthcare services, ensure the availability of quality products, and promote self-medication practices. Such initiatives have created a favorable environment for the growth of the OTC Pharmaceuticals market in the country. In conclusion, the OTC Pharmaceuticals market in Senegal is experiencing growth due to changing customer preferences, emerging trends in the market, and local special circumstances. The increasing demand for OTC products, particularly natural and herbal remedies, along with the rise of e-commerce platforms, has contributed to the expansion of the market. Additionally, the accessibility of OTC pharmaceuticals and the favorable macroeconomic factors in Senegal have further fueled this growth.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)